INTRODUCTION
Prostatic abscess (PA) is an uncommon infection that is generally secondary to Escherichia coli and other members of the Enterobacteriaceae family. In recent years, although rare, more reports of S. aureus PA have been reported [1] . Only 40 cases of staphylococcal PA were reported in the literature through January 2017, of which 26 cases were reported with methicillin-resistant Staphylococcus aureus (MRSA) [2] . Clinical presentation of PA is variable; commonly patients present with fever, chills, dysuria, urinary frequency, and perineal or low back pain [3] . Reported common risk factors of MRSA PA include recent instrumentation, diabetes mellitus, immunosuppression, hepatitis C infection, and intravenous drug use (IDU) [2, 3] . Historically, PA carried a high mortality rate, but that decreased with improving diagnostics and appropriate antibiotics [4] . In view of increasing reports of S. aureus, especially MRSA PA cases, physicians need to consider the prostate as the site of primary or persistent infection in cases of bacteremia in high-risk patients [5] .
In our study, we are reviewing all cases of S. aureus PA admitted to our tertiary center over a 10-year span. To our knowledge, this is the largest reported cohort of patients from a single center.
METHODS
This study is a retrospective review of adult patients admitted to a tertiary care hospital in eastern Tennessee between 2008 and 2018 and who had a diagnosis of S. aureus prostatic abscess. The search term "prostate abscess" was used on the discharge diagnoses to narrow down the search results; only patients who had S. aureus as the culprit organism were included. Clinical, radiographic, and bacteriological data were analyzed. Data were gathered through retrospective chart review of the electronic medical record. The University of Tennessee institution review board approved the study. Tables 1 and 2 After an initial relapse in 2 patients who did not receive adequate source control initially, clinical resolution was observed in the 15 (71%) patients who had follow-up.
RESULTS

Twenty-one patients met the inclusion criteria. Demographic and clinical data were listed in
DISCUSSION
S. aureus is an important human pathogen that causes a diverse spectrum of diseases ranging from minor skin infections to more serious and life-threatening infections, such as bacteremia, endocarditis, and sepsis. The emergence of MRSA, which is resistant to virtually most β-lactam antibiotics, has increased the impact of this pathogen. Methicillin-resistant S. aureus was originally considered a hospital-associated infection, but infection in previously healthy individuals in the community emerged in the 1990s and, so, it now is referred to as community-associated MRSA (CA-MRSA) [6] . The incidence of invasive S. aureus infection has increased in recent years, with similar frequently reported infections irrespective of the methicillin-resistant status (except for the association of methicillin-susceptible S. aureus (MSSA) with septic arthritis), although smaller studies have reported more pneumonia, bacteremia or sepsis, and endocarditis among MRSA patients [7, 8] .
Developing deep-seated and occult abscesses has been described as a complication of S. aureus bacteremia in patients with predisposing risk factors, but PAs continue to be a rare entity with only a few published reports in the literature, mainly as CA-MRSA [2] . In the antibiotic era, the epidemiology of PA has changed from a disease usually affecting young sexually active men to affecting the immunocompromised and debilitated [4] .
In this series, 21 patients with the diagnosis of S. aureus PA were included, the average age was 46 years, and 12 patients had CA-MRSA. and soft tissue infections, a history of genitourinary disease or instrumentation, diabetes mellitus, IDU, hepatitis C infection, and the presence of immunodeficiency state. This is similar to current published literature [2, [9] [10] [11] [12] . One patient had no identifiable risk factors but had MRSA bacteremia, and it is likely that the PA developed from the hematogenous seeding of the prostate after diagnostic delay and inadequate initial antibiotic therapy [13] .
The first published report of the association between IDU and S. aureus PA was by Baker et al in 2004; more reports were published since then especially in CA-MRSA [2, 14] . In our cohort, 38% of patients had history of IDU; this patient population is at higher risk of S. aureus bacteremia (SAB) and possible seeding of the prostate, likely due to increased prevalence of S. aureus colonization, more frequent skin and soft tissue infections, and the sharing of needles [15] .
The most common presentation in our patient's cohort was with genitourinary concerns in 67%. Other complaints included fever, night sweats, altered mental status, weakness or fatigue, and musculoskeletal concerns. This is similar to current published case studies [2, 13] .
Treatment of bacterial prostatitis can be challenging largely because most antibiotics have relatively poor penetration into infected prostate tissue and fluids. Available antibiotics to treat S. aureus PA depending on local drug-resistance patterns include vancomycin, daptomycin, cefazolin, trimethoprimsulfamethoxazole, and fluoroquinolones [16] . All patients in our cohort received antibiotic therapy directed towards S. aurues most commonly with vancomycin; other antibiotics for cohort treatment included daptomycin, cefazolin, and naficillin. One patient who relapsed was treated with drainage and combination therapy, which led to resolution. Dalbavancin was used in 1 patient, and to our knowledge, there are no published reports on its use for this indication. Treatment duration was 6 weeks on average, ranging from 3 to 8 weeks, and the recommended duration of treatment varied depending on the severity of infection and presence of concomitant bacteremia ranging from 2-6 weeks [16] .
There are no established treatment guidelines for PA, and, in most published reports, treatment involves using the appropriate antibiotic toward the most likely pathogen, with or without drainage of the abscess [4] . In Carrol et al, the researchers reviewed 40 cases of S. aureus PA, and 80% of the patients had abscess drainage. Factors affecting the drainage depended on patient's response to antibiotic therapy and the size and accessibility of the abscess [2] . In a single-center retrospective study, Elshal et al recommended a transrectal approach as the best drainage method for select PA cases [17] . This also was recommended by a previous small size study by Aravantinos et al [18] . However, Collad et al reported that transrectal drainage should precede transurethral drainage, due to the potential risk of sexual dysfunction or severe complications associated with transurethral procedures [19] . Furthermore, Vyas et al reported that transrectal drainage benefited patients with abscesses larger than 20 mm presenting with severe lower urinary tract symptoms, or leukocytosis, or both [20] . Kazuhiko et al also recommended transrectal drainage except in cases of multiple abscesses with a long axis exceeding 30 mm [21] . There is a need for a large-size randomized study of optimal selection of drainage methods.
Duration to SAB clearance was 5.8 days in our cohort, all patients received antibiotics immediately after admission, and work up, including image studies, was performed to rule out suppurative complications after blood cultures failed to clear by Day 3. When PA was diagnosed, source control was performed in 17 patients [22] . Six patients in our cohort were lost to follow-up, but of the remaining 15 who had clinical resolution, 2 patients with large PA of more than 38 mm had an initial relapse after being initially treated conservatively. Appropriate drainage then was performed with resolution. This is similar to the published literature, stressing the importance of prompt identification and management of S. aureus PA to decreasing mortality rate and improving outcomes [2, 13] .
Due to the increasing number of IDU at our institution, a multidisciplinary task force was formed with representatives from infectious diseases, psychiatry, cardiac surgery, infection control, and hospital leaders. The task force's aim was to standardize diagnostic algorithms and treatment plans for these high risk patients in order to improve outcomes.
There are a number of limitations in our study. First, cases were identified from discharge summary diagnosis codes, so there is a possibility that some PA cases may not have been identified using this method. Second, although this is a rare diagnosis, it is difficult to draw firm conclusions regarding best treatment approaches due to the limited sample size. Further reporting and research on S. aureus PA cases with a standardized approach is needed to assist physicians in understanding pathogenesis and best treatment options.
Prostate abscess caused by S. aureus infections are a rare complication, and it is often cited as being secondary to MRSA in published literature. In lieu of a lack of published guidelines on appropriate management, the best approach is early diagnosis, drainage, and administration of appropriate antibiotics. In high risk patients with persistent bacteremia, physicians need to consider the prostate as a site of infection.
